| HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. | |
| | |
MedLine Citation:
|
PMID: 21621859 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVES: The presence of MRI lesions at the first demyelinating event increases the risk of developing clinically definite multiple sclerosis (MS). The HLA DRB1*1501 genotype is linked to MS susceptibility but its relationship to quantitative MRI parameters at the first demyelinating event has not been assessed. The objectives were to assess the associations between HLA DRB1*1501 status and magnetic resonance imaging (MRI) measures in clinically isolated syndromes (CIS) at the first demyelinating event. METHODS: We genotyped 205 CIS patients (age: 29.0±7.7years) enrolled in the Observational Study of Early Interferon beta 1-a Treatment in High Risk Subjects after CIS (SET study), a multi-center, clinical study of CIS for rs3135005, a single nucleotide polymorphism associated with HLA DRB1*1501 status. The inclusion criteria required 2 or more brain MRI lesions and the presence of two or more oligoclonal bands in cerebrospinal fluid. Clinical and MRI assessments were obtained within 4months of the initial demyelinating event. RESULTS: The frequency of HLA DRB1*1501 positivity was 102/205 (49.7%). HLA DRB1*1501 positivity was associated with higher contrast-enhancing (CE) lesion number (p=0.002), higher CE-lesion volume (LV) (p<0.001) and exhibited a trend with higher T2-LV (p=0.012). There was no evidence for significant associations of HLA DRB1*1501 positivity with disability, symptoms at CIS presentation, whole brain, white and gray matter atrophy. CONCLUSIONS: HLA DRB1*1501 positivity is associated with increased brain inflammatory processes at first clinical onset. However, the effect sizes of the HLA DRB1*1501 associations with MRI are modest, which potentially limits the clinical usefulness. |
| | |
Authors:
|
Dana Horakova; Robert Zivadinov; Bianca Weinstock-Guttman; Eva Havrdova; Miriam Tamaño-Blanco; Michaela Tyblova; Sara Hussein; Niels Bergsland; Laura Willis; Jan Krasensky; Manuela Vaneckova; Zdenek Seidl; Petra Lelkova; Murali Ramanathan |
Related Documents
:
|
8668779 - Adverse reactions to contrast media in ct: effects of temperature and ionic property. 9533919 - Noise-immune coil for unshielded magnetic resonance measurements 20653329 - Contrast agents used in cardiovascular magnetic resonance imaging: current issues and f... 12897709 - Ct imaging of angiogenesis. 7791549 - Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent... 12643749 - Macromolecular mri contrast agents with small dendrimers: pharmacokinetic differences b... 10361909 - Localized pericarditis with calcifications mimicking a pericardial tumor. 9395159 - A comprehensive method of assessing routine ct scans in schizophrenia. 1739589 - Imaging of the salivary glands. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-27 |
Journal Detail:
|
Title: Journal of neuroimmunology Volume: - ISSN: 1872-8421 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8109498 Medline TA: J Neuroimmunol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011. Published by Elsevier B.V. |
Affiliation:
|
Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anti-myelin associated glycoprotein antibodies recognize HNK-1 epitope on CNS.
Next Document: Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-? polymorphisms with risk and clinical course of ...